References
- Kenemans P. Postmenopausal hormone therapy and breast cancer: what is the problem?. Maturitas 2005; 51: 75–82
- Liotta L A, Stetler-Stevenson W G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991; 51: 5054s–5059s
- Mantovani A. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 1994; 71: 5–16
- Hagemann T, Robinson S C, Schulz M, Trümper L, Balkwill F R, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004; 25: 1543–1549
- Carswell E A, Old L J, Kassel R I, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975; 72: 3666–3670
- Moore R J, Owens D M, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nature Med 1999; 5: 828–831
- Malik S TA, Naylor S, East N, Oliff A, Balkwill F R. Cells secreting tumor necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 1990; 26: 1031–1034
- Orosz P, Kruger A, Hubbe M, Ruschoff J, Von Hoegen P, Mannel D N. Promotion of experimental liver metastasis by tumor necrosis factor. Int J Cancer 1995; 60: 867–871
- Robinson S C, Scott K A, Balkwill F R. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α. Eur J Immunol 2002; 32: 404–412
- Leber T M, Balkwill F R. Regulation of monocyte MMP-9 production by TNF-α and a tumour-derived soluble factor (MMPSF). Br J Cancer 1998; 78: 724–732
- Matsushima K, Larsen C G, DuBois G C, Oppenheim J J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human monocytic cell line. J Exp Med 1989; 169: 1485–1490
- Rollins B J. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996; 2: 198–204
- Oppenheim J J, Zachariae C OC, Mukaida N, Matsushuma K. Properties of the novel proinflammatory supergene ‘intercrine’ cytokine family. Annu Rev Immunol 1991; 9: 617–648
- Inadera H, Sekiya T, Yoshimura T, Matsushima K. Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology 2000; 141: 50–59
- Nesbit M, Schaider H, Miller T H, Herlyn M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 2001; 166: 6483–6490
- Harmey J H, Bouchier-Hayes D. Vascular endothelial growth factor (VEGF), a survival factor for tumor cells: implications for anti-angiogenic therapy. BioEssays 2002; 24: 280–283